More than 1,500 people who have sought support from the vaccine damage payment scheme after being injured or bereaved as a ...

A booster shot is an ... Health Canada has approved the Moderna Spikevax, Pfizer-BioNTech Cominarty, AstraZeneca Vaxevria and Janssen (Johnson & Johnson) vaccines for use in Canada.

While the headline numbers don't inspire much confidence, Moderna is a stock that deserves a closer look. The company still has several fundamental strong points, including an extensive pipeline of ...

Moderna has reported preliminary clinical ... "We believe that a bivalent booster vaccine, if authorised, would create a new tool as we continue to respond to emerging variants," added Bancel.

Moderna's recent stumbles make the company an acquisition target. Merck desperately needs Moderna's mRNA-based Personal Cancer Vaccines ("PCVs") to extend KEYTRUDA's patent protection beyond 2028.

The company is seeking authorisation for a fourth dose of SpikeVax to any adult who has received an initial booster of any of the authorised or approved COVID-19 vaccines. Unlike Pfizer ...

researchers recommended that people who received it get a second booster dose with an mRNA vaccine such as Moderna and Pfizer. According to the published results, there were 129 coronavirus ...

The biotech, renowned for its pioneering development of vaccines ... could be the booster shot the stock needs to generate a rebound. Let's discuss the pros and cons of buying Moderna stock.

The intramuscular vaccine — like the Pfizer and Moderna shots that usually go into ... “So by using this nasal booster,” she told Vox, “we’re really able to prevent the infection and ...

A mass vaccination site in Tokyo’s Minato ... Inc. can be administered to people 12 and older, while Moderna Inc.’s Omicron booster is authorized for those 18 and older. In the past two ...